Virological Follow-up of Adults Living with HIV on Dolutegravir in an Approved Treatment Center in Douala (Cameroon)
Ngondi Dalle Grâce, Boma Bang Luc Vital, Essola Josiane, Ndjengue Nson Louis Sides, Medi Sike Christiane, Nke Ateba Gisèle, Penda Ida Calixte, Okalla Ebongue Cécile & Nda Mefoo Jean Pierre · Journal of Advances in Biology & Biotechnology · 2023
Background: Human immunodeficiency virus infection constitutes one of the greatest contemporary human pandemics, lethal in the absence of treatment. WHO 2018 recommendations have placed Dolutegravir-based treatment as first-line treatment, particularly in resource-limited countri...
Open access
Research Article
10.9734/jabb/2023/v26i6637